Bionure Alternatives & Competitors
12 companies similar to Bionure — Clinical stage biotech developing new drugs for CNS diseases.
Companies similar to Bionure
Accure Therapeutics
R&D pharma dedicated to developing innovative medicines to treat patients suffering from C...
GEn1E Lifesciences Inc.
Clinical-stage, Phase 2 company accelerating novel Precision Therapies for I&I and Rare Di...
Neuraly Inc.
We discover and develop revolutionary treatments for neurodegenerative diseases
Rival Readout
Competing with Bionure? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
NeuroGenesis Bio Inc.
Cell Therapies for Neurodegenerative Diseases
Rezolute, Inc.
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
Quince Therapeutics
Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...
Cyxone
Life-changing treatments for disorders of the immune system
Akari Therapeutics, Plc
Advancing Next-Generation Antibody Drug Conjugates Designed with Novel ImmunoOncology Payl...
Autifony Therapeutics
Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders
Emmaus Life Sciences, Inc
Improving the lives of people with rare disease.
AGTC
Visionary science for life-changing cures.
About Bionure
Bionure is a clinical-stage biotech company focused on developing therapies for neurodegenerative diseases that currently lack treatment options. The company's lead candidate, BN201, is a first-in-class small molecule drug that has shown promising results in promoting neuroprotection and remyelination in animal models...
Biotech, Neurodegenerative Diseases, Clinical Stage, Drug Development, Neuroprotection, Remyelination, Orphan Designation, Ophthalmology, Rare Diseases, SGK Agonists, Optic Neuritis, Neuromyelitis Optica, Multiple Sclerosis, Neuro-inflammation, Clinical Trials
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Bionure: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Bionure on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.